Organogenesis Holdings ORGO Insider Ownership

NASDAQ ORGO
$1.58 -0.02 (-1.56%)
As of: Sep 9, 2026 · 12:05 PM EDT

Insider Holdings by Owner

752.64Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2023
Insider Ownership
11.66%
-0.031% pp QoQ
Shares Held by Insiders
15.56Mn
filed for Sep 2023
0.00% QoQ
Shares Outstanding
130.85Mn
130,848,995 shares
Direct Holdings
0
Indirect: 15.56Mn
Net Shares Traded (QoQ)
0
no net change in Sep 2023
Insiders Holding Shares
24
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2023

As of September 09, 2026, Organogenesis Holdings's top three insider holders are Erani Family Trust Dated 12/29/2012 Albert (TenPercentOwner, 118.90Mn shares), Erani 2012 Issue Trust Dated 12/20/12 Dennis (TenPercentOwner, 118.90Mn shares), Holdings, Llc Red (TenPercentOwner, 118.90Mn shares).

Form 4 Holdings

Insiders Holding ORGO

Insiders 24
Shares held 752.64Mn
Of outstanding 575.20%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Holdings, Llc Red TenPercentOwner 59,448,027 59,448,027 118,896,054 15.8% 30 Dec, 2021
2 Dennis Erani TenPercentOwner 59,448,027 59,448,027 118,896,054 15.8% 17 Dec, 2021
3 Erani Family Trust Dated 12/29/2012 Albert TenPercentOwner 59,448,027 59,448,027 118,896,054 15.8% 30 Dec, 2021
4 Erani 2012 Issue Trust Dated 12/20/12 Dennis TenPercentOwner 59,448,027 59,448,027 118,896,054 15.8% 17 Dec, 2021
5 Alan A. Ades Director, TenPercentOwner 51,085,402 51,085,402 102,170,804 13.6% 13 Jan, 2025
6 2016 Organo 10-Year Grat U/A/D September 30, 2016 Gn TenPercentOwner 59,448,027 0 59,448,027 7.9% 22 Nov, 2021
7 Albert Erani TenPercentOwner 51,585,403 0 51,585,403 6.9% 14 Nov, 2024
8 2016 Family Trust U/A/D August 12, 2016 Gn TenPercentOwner 51,085,403 0 51,085,403 6.8% 02 Dec, 2024
9 Gary S. Gillheeney President And Ceo 4,232,087 0 4,232,087 0.6% 03 Mar, 2026
10 Glenn H Nussdorf Director 2,565,591 0 2,565,591 0.3% 18 Dec, 2025
11 Patrick Bilbo Chief Operating Officer 1,128,312 0 1,128,312 0.1% 03 Mar, 2026
12 Lori Freedman Chief Admin. And Legal Officer 1,023,643 0 1,023,643 0.1% 03 Mar, 2026
13 Brian Grow Chief Commercial Officer 899,724 0 899,724 0.1% 03 Mar, 2026
14 David Francisco Chief Financial Officer 731,312 0 731,312 0.1% 03 Mar, 2026
15 Arthur S Leibowitz Director 291,014 0 291,014 0.0% 11 Mar, 2026
16 Robert Cavorsi Vice President, Strategy 275,524 0 275,524 0.0% 03 Mar, 2026
17 Prathyusha Duraibabu Director 247,047 0 247,047 0.0% 20 Feb, 2026
18 Jon L Giacomin Director 241,026 0 241,026 0.0% 20 Feb, 2026
19 Gilberto Quintero Director 239,073 0 239,073 0.0% 20 Feb, 2026
20 Michele Ilene Korfin Director 239,073 0 239,073 0.0% 20 Feb, 2026
21 Antonio S. Montecalvo Vice President, Health Policy 226,238 0 226,238 0.0% 03 Mar, 2026
22 Michael Joseph Driscoll Director 225,707 0 225,707 0.0% 11 Mar, 2026
23 Garrett Lustig Director 125,742 0 125,742 0.0% 20 Feb, 2026
24 Michael W Katz TenPercentOwner 76,382 0 76,382 0.0% 22 Nov, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

647 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2023
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
09 Mar, 2026 Arthur S Leibowitz Director Acquired P 5,000 $2.68 $13.41K 291,014 Direct
09 Mar, 2026 Michael Joseph Driscoll Director Acquired P 10,000 $2.67 $26.69K 225,707 Direct
18 Feb, 2026 Brian Grow Chief Commercial Officer Acquired A 48,818 $0.00 $0 911,611 Direct
18 Feb, 2026 David Francisco Chief Financial Officer Acquired A 44,040 $0.00 $0 745,999 Direct
01 Mar, 2026 Robert Cavorsi Vice President, Strategy Disposed F 700 $3.21 $2.25K 275,524 Direct
18 Feb, 2026 Gary S. Gillheeney President And Ceo Acquired A 188,856 $0.00 $0 4,323,398 Direct
18 Feb, 2026 Patrick Bilbo Chief Operating Officer Acquired A 49,102 $0.00 $0 1,144,687 Direct
18 Feb, 2026 Antonio S. Montecalvo Vice President, Health Policy Acquired A 11,330 $0.00 $0 230,016 Direct
18 Feb, 2026 Robert Cavorsi Vice President, Strategy Acquired A 16,454 $0.00 $0 281,711 Direct
18 Feb, 2026 Lori Freedman Chief Admin. And Legal Officer Acquired A 43,212 $0.00 $0 1,038,054 Direct
18 Feb, 2026 Lori Freedman Chief Admin. And Legal Officer Disposed F 14,411 $3.84 $55.34K 1,023,643 Direct
18 Feb, 2026 Gary S. Gillheeney President And Ceo Disposed F 91,311 $3.84 $350.63K 4,232,087 Direct
18 Feb, 2026 Patrick Bilbo Chief Operating Officer Disposed F 16,375 $3.84 $62.88K 1,128,312 Direct
18 Feb, 2026 Brian Grow Chief Commercial Officer Disposed F 11,887 $3.84 $45.65K 899,724 Direct
18 Feb, 2026 David Francisco Chief Financial Officer Disposed F 14,687 $3.84 $56.40K 731,312 Direct
18 Feb, 2026 Antonio S. Montecalvo Vice President, Health Policy Disposed F 3,778 $3.84 $14.51K 226,238 Direct
18 Feb, 2026 Robert Cavorsi Vice President, Strategy Disposed F 5,487 $3.84 $21.07K 276,224 Direct
18 Feb, 2026 Gilberto Quintero Director Acquired A 48,828 $0.00 $0 239,073 Direct
18 Feb, 2026 Jon L Giacomin Director Acquired A 48,828 $0.00 $0 241,026 Direct
18 Feb, 2026 Michael Joseph Driscoll Director Acquired A 48,828 $0.00 $0 215,707 Direct